NMR - Nomura Holdings, Inc.

NYSE - NYSE Delayed price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

Currency in JPY. All numbers in thousands
Breakdown
ttm
30/03/2019
30/03/2018
30/03/2017
30/03/2016
Total revenue
1,183,207,000
1,033,126,000
1,397,970,000
1,307,331,000
1,258,039,000
Cost of revenue
-
-
-
-
-
Gross profit
-
-
-
-
-
Operating expenses
Research development
-
-
-
-
-
Selling general and administrative
693,015,000
700,845,000
752,184,000
706,776,000
799,993,000
Total operating expenses
-
-
-
-
-
Operating income or loss
-
-
-
322,795,000
165,158,000
Interest expense
763,803,000
718,348,000
475,189,000
312,319,000
327,415,000
Total other income/expenses net
-
-
-
-
-
Income before tax
151,481,000
-37,701,000
328,158,000
322,795,000
165,158,000
Income tax expense
46,419,000
57,010,000
103,866,000
80,229,000
22,596,000
Income from continuing operations
105,062,000
-94,711,000
224,292,000
242,566,000
142,562,000
Net income
99,975,000
-100,442,000
219,343,000
239,617,000
131,550,000
Net income available to common shareholders
99,975,000
-100,442,000
219,343,000
239,617,000
131,550,000
Reported EPS
Basic
-
-29.90
63.13
67.29
36.53
Diluted
-
-29.92
61.88
65.65
35.52
Weighted average shares outstanding
Basic
-
3,359,565
3,474,593
3,560,776
3,600,701
Diluted
-
3,359,567
3,543,603
3,649,916
3,703,547
EBITDA
-
-
-
-
-